Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Assessment of Clonal Evolution in 42 AML with NPM1 Mutations by Molecular Characterization of Paired Diagnosis and Relapse Samples

Jan Krönke, Lars Bullinger, Frank G. Rücker, Verena I. Gaidzik, MD, Michael WM Kühn, Karin Bezet, Veronica Teleanu, Peter Paschka, MD, Daniela Späth, Thomas Kindler, MD, Helmut R. Salih, MD, Jürgen Krauter, MD, Arnold Ganser, MD, Gudrun Göhring, MD, Brigitte Schlegelberger, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner

Blood (2011) 118 (21): 237.

https://doi.org/10.1182/blood.V118.21.237.237

Published: 2011

Journal Articles

Integrative Genomics Approaches Identify Novel Disease-Related Genetic Aberrations in Acute Myeloid Leukemia

Anna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, Frank G Rücker, Jan Krönke, Michael WM Kühn, Peter Paschka, MD, Verena I. Gaidzik, MD, Sabine Kayser, Richard F. Schlenk, MD, Berit Haldemann, Stephan Wolf, Hartmut Döhner, MD, Claudio Lottaz, Konstanze Döhner, MD, Lars Bullinger

Blood (2011) 118 (21): 402.

https://doi.org/10.1182/blood.V118.21.402.402

Published: 2011

Journal Articles

Genome-Wide Genotyping of Acute Myeloid Leukemia with t(9;11) Reveals New Recurrent Genomic Alterations,

Michael W.M. Kühn, MD, Lars Bullinger, Jennifer Edelmann, MD, Jan Krönke, MD, Gröschel Stefan, MD, Frank G. Rücker, Peter Paschka, MD, Verena I. Gaidzik, MD, Karlheinz Holzmann, PhD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD

Blood (2011) 118 (21): 3546.

https://doi.org/10.1182/blood.V118.21.3546.3546

Published: 2011

Journal Articles

TP53 Alterations in Acute Myeloid Leukemia with Complex Karyotype Correlate with Specific Copy Number Alterations, Monosomal Karyotype, and Dismal Outcome,

Blood (2011) 118 (21): 3558.

https://doi.org/10.1182/blood.V118.21.3558.3558

Published: 2011

Journal Articles

Genetic and Epigenetic Profiling on 7q22 Identifies ATXN7L1 As Candidate Tumor Suppressor in Acute Myelogenous Leukemia

Anna R Poetsch, Rainer Claus, Jacques Bonnet, Didier Devys, Frank G. Rücker, László Tora, Konstanze Döhner, MD, Hartmut Döhner, MD, Christoph Plass

Blood (2011) 118 (21): 1408.

https://doi.org/10.1182/blood.V118.21.1408.1408

Published: 2011

Journal Articles

NF1 Alterations Are Common In AML with Complex Karyotype and Correlate with Specific Genomic Imbalances

Frank G. Rücker, MD, Lars Bullinger, MD, Frank Stegelmann, MD, Carmen Blersch, Peter Lichter, PhD, Jürgen Krauter, MD, Brigitte Schlegelberger, MD, PhD, Arnold Ganser, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD

Blood (2010) 116 (21): 4179.

https://doi.org/10.1182/blood.V116.21.4179.4179

Published: 2010

Journal Articles

Induction Therapy with Idarubicin and Etoposide Combined with Sequential or Concurrent Azacitidine In Patients with High-Risk Acute Myeloid Leukemia: Pilot-Phase of the AMLSG 12-09 Study

Frank G. Rücker, Stephan Stilgenbauer, M.D., Martin Bommer, Daniela Späth, Silja Mack, Konstanze Döhner, Hartmut Döhner, MD, Richard F. Schlenk, MD

Blood (2010) 116 (21): 2184.

https://doi.org/10.1182/blood.V116.21.2184.2184

Published: 2010

Journal Articles

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

Verena I. Gaidzik, M.D., Cailian Wang, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Peter Paschka, M.D., Frank G. Rücker, M.D., Andrea Corbacioglu, Ph.D., Karina Eiwen, Jürgen Krauter, M.D., Brigitte Schlegelberger, MD, Arnold Ganser, M.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Hartmut Döhner, M.D., Konstanze Döhner, M.D.

Blood (2009) 114 (22): 1600.

https://doi.org/10.1182/blood.V114.22.1600.1600

Published: 2009

Journal Articles

In Acute Myeloid Leukemia with Complex Karyotype TP53 Alterations Are Associated with Specific Genomic Aberrations and Predict Inferior Survival.

Frank G Rücker, M.D., Richard F Schlenk, M.D., Lars Bullinger, M.D., Helena Kett, Annegret Becker, Carla-Maria Kugler, Thorsten Zenz, MD, Peter Lichter, Ph.D., Jürgen Krauter, M.D., Brigitte Schlegelberger, M.D., Arnold Ganser, M.D., Hartmut Döhner, M.D., Konstanze Döhner, M.D.

Blood (2009) 114 (22): 2632.

https://doi.org/10.1182/blood.V114.22.2632.2632

Published: 2009

Journal Articles

SNP-Array Profiling Identifies Complex Aberrations and Candidate Genes in Myeloproliferative Neoplasms with Leukemic Transformation.

Frank Stegelmann, Martin Griesshammer, Karlheinz Holzmann, Frank G Rücker, Carmen Blersch, Susanne Kuhn, Stefanie Schauer, Hartmut Dohner, Konstanze Dohner

Blood (2009) 114 (22): 2608.

https://doi.org/10.1182/blood.V114.22.2608.2608

Published: 2009

Journal Articles

Genetic Profiling of BCR/ABL Negative Myeloproliferative Disorders Using High-Resolution Microarrays

Frank Stegelmann, MD, Martin Griesshammer, MD, Sandra Ruf, Susanne Kuhn, Frank G. Rücker, MD, Simone Miller, Hartmut Dohner, MD, Konstanze Dohner, MD

Blood (2007) 110 (11): 1538.

https://doi.org/10.1182/blood.V110.11.1538.1538

Published: 2007

Journal Articles

Identification of High-Level DNA Amplifications in AML with Complex Karyotype Using Array-CGH.

Frank G. Rücker, MD, Lars Bullinger, MD, Simone Miller, Hans A. Kestler, PhD, Peter Lichter, PhD, Konstanze Dohner, MD, Hartmut Dohner, MD

Blood (2006) 108 (11): 1914.

https://doi.org/10.1182/blood.V108.11.1914.1914

Published: 2006

Journal Articles

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

Konstanze Döhner, Richard F. Schlenk, Marianne Habdank, Claudia Scholl, Frank G. Rücker, Andrea Corbacioglu, Lars Bullinger, Stefan Fröhling, Hartmut Döhner, for the AML Study Group (AMLSG)

Blood (2005) 106 (12): 3740–3746.

https://doi.org/10.1182/blood-2005-05-2164

Published: 2005

NARROW

Assessment of Clonal Evolution in 42 AML with NPM1 Mutations by Molecular Characterization of Paired Diagnosis and Relapse Samples

Integrative Genomics Approaches Identify Novel Disease-Related Genetic Aberrations in Acute Myeloid Leukemia

Genome-Wide Genotyping of Acute Myeloid Leukemia with t(9;11) Reveals New Recurrent Genomic Alterations,

TP53 Alterations in Acute Myeloid Leukemia with Complex Karyotype Correlate with Specific Copy Number Alterations, Monosomal Karyotype, and Dismal Outcome,

Genetic and Epigenetic Profiling on 7q22 Identifies ATXN7L1 As Candidate Tumor Suppressor in Acute Myelogenous Leukemia

NF1 Alterations Are Common In AML with Complex Karyotype and Correlate with Specific Genomic Imbalances

Induction Therapy with Idarubicin and Etoposide Combined with Sequential or Concurrent Azacitidine In Patients with High-Risk Acute Myeloid Leukemia: Pilot-Phase of the AMLSG 12-09 Study

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

In Acute Myeloid Leukemia with Complex Karyotype TP53 Alterations Are Associated with Specific Genomic Aberrations and Predict Inferior Survival.

SNP-Array Profiling Identifies Complex Aberrations and Candidate Genes in Myeloproliferative Neoplasms with Leukemic Transformation.

Genetic Profiling of BCR/ABL Negative Myeloproliferative Disorders Using High-Resolution Microarrays

Identification of High-Level DNA Amplifications in AML with Complex Karyotype Using Array-CGH.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only